← Back to Patent Explorer
US4207307A Expired / Lapsed US ⏱️ 0.0 years remaining

Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites

Assignee: Research Corp
•
Filing: 1977-01-21
•
Granted: 1980-06-10
•
Expires: 1997-01-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention includes an antigenic conjugate of ecgonine and a carrier which elicits anti-benzoylecgonine (cocaine metabolite) serum useful for the detection of cocaine metabolites in human organs and body fluids by immunoassay. The invention also includes the method of producing the anti-benzoylecgonine serum, the immunoassay method and composition including the anti-benzoylecgonine serum and a labeled benzoylecgonine and a non-labeled benzoylecgonine. The invention also includes a composition comprising a plurality of antigenic conjugates which elicit a multivalent anti-serum capable of complexing a plurality of antigens in a multiple immunoassay detection method. The invention includes the method of producing the multivalent anti-serum and an immunoassay method employing the multivalent anti-serum. The invention further includes a composition comprising the multivalent anti-serum and a plurality of labeled antigens and non-labeled antigens.

Inventors

  • 👤 Balkrishena Kaul
  • 👤 Bernard Davidow
  • 👤 Stephen J. Millian

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 03:35
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; C; C07; C07K; C07K16/00; C07K16/44; G01N33/94; G01N33/946; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S436/00; Y10S436/815; Y10S436/816; Y10S436/819

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 145 words
A composition which forms a multivalent anti-serum upon immunization of an animal therewith, said multivalent anti-serum being capable of complexing a plurality of antigens in a multiple immunoassay containing at least two of, (1) an antigenic conjugate of ecgonine or the acetate thereof and a peptide, protein or polysaccharide, (2) an antigenic conjugate of carboxylmethylmorphine and a peptide, protein or polysaccharide, (3) an antigenic conjugate of 5-ethyl-5-(1-carboxyl-n-propyl) barbituric acid and a peptide, protein or polysaccharide, (4) an antigenic conjugate of oxazepam and a peptide, protein or polysaccharide, and (5) an antigenic conjugate of nortriptyline or desmethylimipramine and a peptide, protein or polysaccharide, said composition being capable of eliciting a multivalent anti-serum which complexes at least two of the antigens: (1) benzoylecgonine, ecgonine and cocaine, (2) opiates, (3) barbiturates, (4) benzodiazepenes and (5) tricyclic anti-depressants in a multiple immunoassay of said antigens in a biological fluid.
Claim 2
Dependent Claim 145 words
A composition which forms a multivalent anti-serum upon immunization of an animal therewith, said multivalent anti-serum being capable of complexing a plurality of antigens in a multiple immunoassay containing at least two of, (1) an antigenic conjugate of ecgonine or the acetate thereof and a peptide, protein or polysaccharide, (2) an antigenic conjugate of carboxylmethylmorphine and a peptide, protein or polysaccharide, (3) an antigenic conjugate of 5-ethyl-5-(1-carboxyl-n-propyl) barbituric acid and a peptide, protein or polysaccharide, (4) an antigenic conjugate of oxazepam and a peptide, protein or polysaccharide, and (5) an antigenic conjugate of nortriptyline or desmethylimipramine and a peptide, protein or polysaccharide, said composition being capable of eliciting a multivalent anti-serum which complexes at least two of the antigens: (1) benzoylecgonine, ecgonine and cocaine, (2) opiates, (3) barbiturates, (4) benzodiazepenes and (5) tricyclic anti-depressants in a multiple immunoassay of said antigens in a biological fluid.
Claim 3
Independent Claim 51 words
A method of producing an anti-sera suitable for use in a simultaneous multiple immunoassay of a plurality of antigens in a biological tissue or fluid comprising immunizing an animal by injection with a plurality of antigens and eliciting a multivalent anti-sera from said animal capable of complexing a plurality of antigens.
Claim 4
Independent Claim 51 words
A method of producing an anti-sera suitable for use in a simultaneous multiple immunoassay of a plurality of antigens in a biological tissue or fluid comprising immunizing an animal by injection with a plurality of antigens and eliciting a multivalent anti-sera from said animal capable of complexing a plurality of antigens.
Claim 5
Dependent Claim 14 words
The method of claim 2 wherein said antigens are injected simultaneously into said animal.
Claim 6
Dependent Claim 14 words
The method of claim 2 wherein said antigens are injected sequentially into said animal.
Claim 7
Dependent Claim 82 words
The method of claim 2 wherein said antigens injected into said animal are two or more of: (1) an antigenic conjugate of ecgonine and a peptide, protein or polysaccharide, (2) an antigenic conjugate of carboxylmethylmorphine and a peptide, protein or polysaccharide, (3) an antigenic conjugate of 5-ethyl-5-(1-carboxyl-n-propyl) barbituric acid and a peptide, protein or polysaccharide, (4) an antigenic conjugate of oxazepam and a peptide, protein or polysaccharide, and (5) an antigenic conjugate of nortriptyline or desmethylimipramine and a peptide, protein or polysaccharide.
Claim 8
Dependent Claim 9 words
The anti-sera produced by the method of claim 2.
Claim 9
Dependent Claim 9 words
The anti-sera produced by the method of claim 5.
Claim 10
Dependent Claim 61 words
In a method for the simultaneous multiple immunoassay of a plurality of antigens in a biological tissue or fluid, wherein a multi-valent anti-serum is combined with said biological tissue or fluid to form complexes with said plurality of antigens, said complexes being capable of detection in an assay, the improvement comprising employing the anti-sera of claim 6 to form said complexes.
Claim 11
Dependent Claim 61 words
In a method for the simultaneous multiple immunoassay of a plurality of antigens in a biological tissue or fluid, wherein a multi-valent anti-serum is combined with said biological tissue or fluid to form complexes with said plurality of antigens, said complexes being capable of detection in an assay, the improvement comprising employing the anti-sera of claim 7 to form said complexes.
Claim 12
Dependent Claim 40 words
A composition suitable for use in a simultaneous multiple immunoassay of a plurality of antigens in a biological tissue or fluid comprising the anti-sera of claim 6 and a plurality of labeled antigens corresponding to the antigens to be detected.
Claim 13
Dependent Claim 58 words
A composition suitable for use in a simultaneous multiple radioimmunoassay of a plurality of antigens comprising the anti-sera of claim 7 and a plurality of the radiolabeled antigens (1) I 125 -benzoylecgonine derivative, (2) I 125 or tritiated morphine, (3) I 125 or tritiated secobarbitol, (4) I 125 or tritiated diazepam and (5) I 125 or tritiated nortriptyline.
Claim 14
Dependent Claim 13 words
A composition comprising the anti-sera of claim 6 and a plurality of antigens.
Claim 15
Dependent Claim 84 words
A composition comprising the anti-sera of claim 7 and a plurality of the antigens: (1) an antigenic conjugate of ecgonine or the acetate thereof and a peptide, protein or polysaccharide, (2) an antigenic comjugate of carboxylmethylmorphine and a peptide, protein or polysaccharide, (3) an antigenic conjugate of 5-ethyl-5-(1-carboxyl-n-propyl) barbituric acid and a peptide, protein or polysaccharide, (4) an antigenic conjugate of oxazepam and a peptide, protein or polysaccharide, and (5) an antigenic conjugate of nortriptyline or desmethyl imipramine and a peptide, protein or polysaccharide.

References Cited (Backward Citations)

US4022878A Cited
US4031199A Cited
US4045420A Cited
US3888866A Cited
US3917582A Cited
US3952091A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-06-10 1983-12-10 1984-06-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-06-10 1987-12-10 1988-06-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-06-10 1991-12-10 1992-06-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag